Radiopharm Theranostics Limited

RADX · NASDAQ
Analyze with AI
12/31/2024
9/30/2024
6/30/2024
3/31/2024
Operating Activities
Net Income$0$0$0$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0$0$0
Other Non-Cash-$9-$13-$7-$4
Operating Cash Flow-$9-$13-$7-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$3$0$0
Investing Cash Flow$0$3$0$0
Financing Activities
Debt Repay.$0$0$0$2
Stock Issued$0$46$24$3
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$7-$2-$0
Financing Cash Flow-$2$39$23$5
Forex Effect$1-$0-$0$0
Net Chg. in Cash-$10$28$16$1
Supplemental Information
Beg. Cash$46$19$3$2
End Cash$36$46$19$3
Free Cash Flow-$9-$13-$7-$4
Radiopharm Theranostics Limited (RADX) Financial Statements & Key Stats | AlphaPilot